AbbVie Aktie

192,26 EUR +1,78 EUR +0,93 %

15:43:30

STU

202,65 USD +1,71 USD +0,85 %

17:56:21

BTT

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

JETZT LOSLEGEN

Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handeln Smartphone

Marktkap.338,61 Mrd. EUR

KGV74,34Div. Rendite3,54%

WKNA1J84E

ISINUS00287Y1091

SymbolABBV

AbbVie Aktien News

Sortieren:Datum Meistgelesen

15.11.24ZacksAbbVie Stock Falls 11% in a Month: Should You Buy the Dip?

15.11.24MotleyFoolGot $1,500 to Invest? AbbVie Just Proved the Bull Thesis for Its Stock

14.11.24PR NewswireAbbVie Awards 20 Individuals Living With Migraine To Support Career Aspirations

12.11.24ZacksAbbVie Stock Declines as Schizophrenia Studies Fail, BMY Gains

12.11.24BenzingaNavigating 14 Analyst Ratings For AbbVie

11.11.24MotleyFoolWhy AbbVie Stock Was Getting Mashed on Monday

11.11.24BenzingaThis Is What Whales Are Betting On AbbVie

11.11.24MarketWatchBristol Myers Squibb’s stock soars after rival AbbVie reports disappointing schizophrenia-drug trial

11.11.24BenzingaAbbVie Stock Slips As $9 Billion Schizophrenia Studies Flunk, Bristol-Myers Stock Surges

11.11.24Financial TimesAbbVie shares tumble after schizophrenia drug disappoints

11.11.24PR NewswireAbbVie Provides Update on Phase 2 Results for Emraclidine in Schizophrenia

08.11.24ZacksWall Street Bulls Look Optimistic About AbbVie (ABBV): Should You Buy?

08.11.24ZacksZacks Investment Ideas feature highlights: AbbVie, Visa and Comfort Systems USA

07.11.24PR NewswireAllergan Aesthetics Celebrates Annual BOTOX® Cosmetic (onabotulinumtoxinA) Day

06.11.24BenzingaWhat the Options Market Tells Us About AbbVie

05.11.24ZacksIs Most-Watched Stock AbbVie Inc. (ABBV) Worth Betting on Now?

04.11.24BenzingaHere's How Much $100 Invested In AbbVie 10 Years Ago Would Be Worth Today

01.11.24BenzingaPrice Over Earnings Overview: AbbVie

31.10.24BenzingaMarket Analysis: AbbVie And Competitors In Biotechnology Industry

31.10.24PR NewswireAbbVie and EvolveImmune Therapeutics Announce Collaboration and Option-to-License Agreement to Develop Next-Generation Cancer Biotherapeutics

30.10.24MotleyFoolAbbVie (ABBV) Q3 2024 Earnings Call Transcript

30.10.24ZacksAbbVie Trumps Q3 Earnings & Sales Estimates, Raises '24 EPS View

30.10.24ZacksCompared to Estimates, AbbVie (ABBV) Q3 Earnings: A Look at Key Metrics

30.10.24BenzingaAbbVie Tops Q3 Expectations As Skyrizi, Rinvoq Drive Growth

30.10.24ZacksAbbVie (ABBV) Surpasses Q3 Earnings and Revenue Estimates

29.10.24BenzingaAbbVie Chart Reflects Bearish Signals Ahead Of Q3 Earnings

29.10.24PR NewswireAbbVie's VRAYLAR® (cariprazine) Now Publicly Reimbursed in Ontario

28.10.24PR NewswireAbbVie to Acquire Aliada Therapeutics, Strengthening Focus in Alzheimer's Disease and Neuroscience Pipeline

25.10.24BenzingaForecasting The Future: 11 Analyst Projections For AbbVie

25.10.24ZacksShould AbbVie Stock Be in Your Portfolio Pre-Q3 Earnings?

25.10.24ZacksCurious about AbbVie (ABBV) Q3 Performance? Explore Wall Street Estimates for Key Metrics

24.10.24ZacksAbbVie (ABBV) Outperforms Broader Market: What You Need to Know

24.10.24PR NewswireAbbVie and Gedeon Richter Announce New Collaboration for the Discovery and Development of Novel Targets for Neuropsychiatric Conditions

23.10.24ZacksAnalysts Estimate AbbVie (ABBV) to Report a Decline in Earnings: What to Look Out for

23.10.24ZacksAbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know

22.10.24ZacksThe Zacks Analyst Blog Highlights Johnson & Johnson, Pfizer, Roche, AbbVie and Sanofi

21.10.24PR NewswireNine Provinces Approve Accelerated Public Reimbursement of Diffuse Large B-Cell Lymphoma Treatment Under New Early Access Process

19.10.24PR NewswireBOTOX® Cosmetic (onabotulinumtoxinA) Receives FDA Approval for Moderate to Severe Vertical Bands Connecting the Jaw and Neck (Platysma Bands)

18.10.24ZacksThe Zacks Analyst Blog Highlights AbbVie, Automatic Data Processing, Analog Devices, Taylor Devices and Village Super Market

18.10.24ZacksAbbVie Secures FDA Approval for Parkinson's Disease Drug Vyalev

AbbVie News

AbbVie News: auf dieser Seite finden Sie alle AbbVie News und Nachrichten zur AbbVie Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch AbbVie News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um AbbVie News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.